BioCentury | Jul 15, 2019
Financial News

AI play Recursion raises $121M to expand into new drug discovery

...investors, including Lux Capital, Data Collective, Mubadala Ventures, Two Sigma Ventures, Obvious Ventures, Felicis Ventures, Epic Ventures...
BioCentury | Oct 13, 2017
Finance

Repurposing Recursion

...are undisclosed. Other participants in the B round included existing investors Lux Capital, Obvious Ventures, Epic Ventures...
BioCentury | Oct 10, 2017
Company News

Recursion, Takeda enter rare disease discovery partnership

...led by Data Collective (DCVC), with participation from fellow existing investors Lux Capital, Obvious Ventures, Epic Ventures...
BioCentury | Oct 10, 2016
Financial News

Recursion Pharmaceuticals completes venture financing

...Hematology Date completed: 2016-10-03 Type: Venture financing Raised: $12.9 million Investors: Lux Capital; Obvious Ventures; Epic Ventures...
BioCentury | Oct 3, 2016
Financial News

Repurposing play Recursion raises $12.9M

...Utah) raised $12.9 million in a series A round led by Lux Capital. Obvious Ventures, Epic Ventures...
BioCentury | Sep 17, 2012
Financial News

Exagen completes venture financing

...million Investors: Tullis Health Investors; Sun Mountain Capital; Cottonwood Technology Fund; Mesa Verde Venture Partners; Epic Ventures WIR...
Items per page:
1 - 6 of 6
BioCentury | Jul 15, 2019
Financial News

AI play Recursion raises $121M to expand into new drug discovery

...investors, including Lux Capital, Data Collective, Mubadala Ventures, Two Sigma Ventures, Obvious Ventures, Felicis Ventures, Epic Ventures...
BioCentury | Oct 13, 2017
Finance

Repurposing Recursion

...are undisclosed. Other participants in the B round included existing investors Lux Capital, Obvious Ventures, Epic Ventures...
BioCentury | Oct 10, 2017
Company News

Recursion, Takeda enter rare disease discovery partnership

...led by Data Collective (DCVC), with participation from fellow existing investors Lux Capital, Obvious Ventures, Epic Ventures...
BioCentury | Oct 10, 2016
Financial News

Recursion Pharmaceuticals completes venture financing

...Hematology Date completed: 2016-10-03 Type: Venture financing Raised: $12.9 million Investors: Lux Capital; Obvious Ventures; Epic Ventures...
BioCentury | Oct 3, 2016
Financial News

Repurposing play Recursion raises $12.9M

...Utah) raised $12.9 million in a series A round led by Lux Capital. Obvious Ventures, Epic Ventures...
BioCentury | Sep 17, 2012
Financial News

Exagen completes venture financing

...million Investors: Tullis Health Investors; Sun Mountain Capital; Cottonwood Technology Fund; Mesa Verde Venture Partners; Epic Ventures WIR...
Items per page:
1 - 6 of 6